Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 19 - 20: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
imported>GxPlexBot Import from GxPlex Excel |
||
| Line 4: | Line 4: | ||
|RefDocPart=Article 19 - 20 | |RefDocPart=Article 19 - 20 | ||
|RefLanguage=EN | |RefLanguage=EN | ||
| | |RefTags=TAG-00059-Reg-lat ++ TAG-00013-Adv-art ++ TAG-00008-Cli-ngK ++ TAG-00001-Med-rzn | ||
| | |RefModule=1 | ||
| | |RefUnit=1.5.4 | ||
}} | }} | ||
| Line 14: | Line 14: | ||
|- | |- | ||
! colspan="2" class="gplx-infobox-header" | Reference Details | ! colspan="2" class="gplx-infobox-header" | Reference Details | ||
|- | |||
! Module | |||
| Module 1 — Unit 1.5.4 | |||
|- | |- | ||
! Scope | ! Scope | ||
| Line 30: | Line 33: | ||
| | | | ||
|- | |- | ||
! Tags | ! Tags | ||
| | | [[Glossary:TAG-00059-Reg-lat|Regulatory submission]], [[Glossary:TAG-00013-Adv-art|Advanced-therapy IMP]], [[Glossary:TAG-00008-Cli-ngK|Clinical trial]], [[Glossary:TAG-00001-Med-rzn|Medicinal product]] | ||
|- | |||
| | |||
|- | |||
| | |||
|- | |- | ||
! Comment | ! Comment | ||
Revision as of 17:29, 15 July 2026
| Document information | |
|---|---|
| Reference | GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 |
| Validity area | GBR |
| Scope(s) | HM |
| Document name | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Version / Revision | 01-May-2004 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 1 — Unit 1.5.4 |
| Scope | HM |
| Document part | Article 19 - 20 |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Regulatory submission, Advanced-therapy IMP, Clinical trial, Medicinal product |
| Comment | Authorisation procedure for gene therapy medicinal products |
Content
Authorisation procedure for clinical trials involving medicinal products for gene therapy etc. […] Authorisation procedure for clinical trials involving medicinal products with special characteristics [...]
